L3VLUP
ProSign in

VCEL in the 13F filings

Vericel Corp · CUSIP 92346J108

Sector · Pharmaceuticals and biotechnologyTheme · Biological productsTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
31 Mar 2025
the date the book describes
Filed
15 May 2025
latest of these filings; the earliest 12 May 2025
Managers listing it
3
at least, of 95 tracked, among listed positions
Comparable managers
95
filed both Q4 2024 and Q1 2025; 2 listed it in both
Shares listed
716,807
combined, among listed positions
Reported value
$32m
combined, at the quarter end

Among the 95 comparable managers: 2 buyers (opened or added shares) and 1 seller (trimmed or exited), at least, among listed positions. Their net change in shares was +666,760.

Managers listing VCEL in Q1 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q4 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

3 of 3 holders

ActionFiling
Capital Research Global Investors654,461$29munder 0.1%Newnew12 May 2025 (the filing on sec.gov)
PDT Partners LLC49,325$2.2m0.16%Added+14,61815 May 2025 (the filing on sec.gov)
Winton Group Ltd13,021$581kunder 0.1%Trimmed-2,31915 May 2025 (the filing on sec.gov)

Largest increases and reductions, by shares

Q4 2024 to Q1 2025, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
1 in Q3 2024 to 2 in Q2 2026

Tracked managers listing it, at least.

024620182019202020212023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
VCEL by quarter
QuarterHoldersReported valueBuyersSellers
Q4 20171$1.5mn.a.n.a.
Q1 20182$6.3mn.a.n.a.
Q2 20182$10mn.a.n.a.
Q3 20183$20mn.a.n.a.
Q4 20182$7.4mn.a.n.a.
Q1 20193$19mn.a.n.a.
Q2 20192$14mn.a.n.a.
Q3 20192$10mn.a.n.a.
Q4 20193$12mn.a.n.a.
Q1 20202$7.4mn.a.n.a.
Q2 20202$7.4mn.a.n.a.
Q3 20202$6.8mn.a.n.a.
Q4 20203$19mn.a.n.a.
Q1 20216$68mn.a.n.a.
Q2 20213$37mn.a.n.a.
Q3 20212$5.0mn.a.n.a.
Q4 20211$2.1mn.a.n.a.
Q2 20221$1.3mn.a.n.a.
Q1 20231$27mn.a.n.a.
Q2 20231$19mn.a.n.a.
Q3 20232$21mn.a.n.a.
Q4 20231$479k10
Q1 20242$1.6m20
Q2 20241$1.0m11
Q3 20241$1.0m10
Q4 20242$2.7m11
Q1 20253$32m21
Q2 20252$40m20
Q3 20254$37m21
Q4 20253$11m1617
Q1 20261$1.3m1813
Q2 20262$14m1912

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

VCEL and GILD →VCEL and AMGN →VCEL and ARGX →Choose a stock to compare with VCEL →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own VCEL, latest filings →Back to the 13F Explorer →